The relevance of REV3L mRNA expression in identifying TMZ + ATRi sensitive models is underscored by the significant tumor growth delay and improved survival of mice bearing low-REV3L compared to higher-REV3L TMZ-resistant PDXs, despite those having some response to TMZ as a single agent. The gene discussed is REV3L; the disease is neoplasm.